| April 30,2002 |
Progress in human tumour immunology and
immunotherapy |
|
Studies of the
administration of interleukin-2 to patients with metastatic
melanoma or kidney cancer have shown that immunological
manipulations can mediate the durable regression of metastatic
cancer. The molecular identification of cancer antigens has opened
new possibilities for the development of effective immunotherapies
for patients with cancer. Clinical studies using immunization with
peptides derived from cancer antigens have shown that high levels
of lymphocytes with anti-tumour activity can be raised in
cancer-bearing patients. Highly avid anti-tumour lymphocytes can
be isolated from immunized patients and grown in vitro for use in
cell-transfer therapies. Current studies are aimed at
understanding the mechanisms that enable the cancer to escape from
immune attack. |
| April 29,2002 |
Recent progress in artificial
receptors for phosphate anions in aqueous solution |
|
A recent progress of
artificial phosphate receptors is reviewed with special focus on
macrocyclic polyamines and their metal complexes as a new
prototype. In comparison to most of the previous artificial
receptors most of them are organic molecules ,our system
characteristically works in aqueous solution at neutral pH with
extremely strong affinities with phosphate anions. |
| April 28,2002 |
A Thymic Precursor to the NK T Cell Lineage |
|
CD1d-restricted
autoreactive natural killer (NK1.11) T cells function as
regulatory cells in various disease conditions. Using improved
tetramer tracking methodology, we identified a NK1.1– thymic
precursor and followed its differentiation and emigration to
tissues by direct cell transfer and in situ cell labeling studies. |
| April 27,2002 |
COMPUTING: Successes and Challenges |
|
In the last few years, the idea of a molecular
computer that could execute computational
steps at the scale of a single
molecule has moved from the realm of science
fiction into that of scientific publications. |
| April 26,2002 |
Small Nucleolar RNAs: An Abundant Group of Noncoding RNAs with Diverse Cellular Functions
|
|
Small nucleolar RNAs represent an abundant, evolutionarily ancient group of noncoding RNAs which possess
impressively diverse functions ranging from 2-O-methylation of Various Classes of RNAs ylation and pseudouridylation of various classes of
RNAs, through nucleolytic processing of rRNAs to the
synthesis of telomeric DNA. |
| April 25,2002 |
Lipases and HDL metabolism
|
|
Plasma levels of high-density lipoproteins (HDL) cholesterol are strongly inversely associated with atherosclerotic cardiovascular disease.Here,wefocus on new developments and insights into the role of secreted lipases on HDL metabolism and their relationship to atherosclerosis. |
| April 24,2002 |
Ribosome structure:revisiting the connection between translational accuracy
and unconventional decoding
|
|
This article proposes that the ribosome uses the structure of the codon–anticodon complex formed by the peptidyl-tRNA, especially its wobble interaction, to constrain the incoming aminoacyl-tRNA to the correct reading frame. |
| April 23,2002 |
Signaling Networks
That Link Cell Proliferation and Cell Fate
|
|
In this review, we will
discuss our current understanding of the Rb/E2F pathway, the
c-Myc transcription factor, and the Ras signaling molecule, followed
by recent work showing interconnections between these pathways,
leading to a more comprehensive picture of the network controlling
the balance between cellular proliferation and apoptosis. |
| April 22,2002 |
Adrenomedullin:An Autocrine/Paracrine
Factor for Cardiorenal Protection
|
|
Since 1993, with the discovery of adrenomedullin (AM)
by Kitamura and coworkers,we have gained many
insights into the biology of this new peptide.We now know that AM circulates in plasma and is present in organs and tissues with increases in AM activity in heart failure, hypertension, and renal dysfunction. |
| April 21,2002 |
NF-κB in Cancer: From
Innocent Bystander to Major Culprit
|
|
Although the importance of NF-κB in
immunity is undisputed, recent evidence indicates that NF-κB and the signalling pathways that are involved in its activation are also important for tumour development. |
| April 20,2002 |
Death and Anit-Death:Tumor Resistantce to Apoptosis
|
|
Tumour cells often have faulty apoptotic pathways. These defects not only increase tumour mass, but also render the tumour resistant to therapy. So, what are the molecular mechanisms of tumour resistance to apoptosis and how can we use this knowledge to resensitize tumour cells to cancer therapy? |
| April 19,2002 |
Danger — misfolding proteins
|
|
Protein folding is vital to living organisms because it adds functional flesh to the bare bones of genes. But errors in this process generate misfolded structures that can be lethal. |
| April 18,2002 |
On the offensive
|
|
After decades of disappointment,
and the investment of billions of dollars,is the ‘war on cancer’
about to gain real momentum? Alison Abbott sends a dispatch from the
front line. |
| April 17,2002 |
Mixed signals in heart failure:cancer rules
|
|
Perhaps the time has come to attempt to dissect the mixed signals for heart failure from the viewpoint of
recent advances in cancer biology. On a molecular level,
the failing heart represents the end result of multiple
cues for the growth, death, and survival of cardiac
myocytes, many of which are shared with signaling
pathways in cancer biology. |
| April 16,2002 |
Mitochondria, from
cell death to proliferation
|
|
Mitochondrial signaling cascades have been implicated in the activation of programmed cell death and, more recently, control of cell proliferation. A nuclear gene encoding a mitochondrial Krebs-cycle protein, fumarate hydratase, is now shown to act as a
major tumor-suppressor gene. |
| April 15,2002 |
Embryo and stem cell
research in the USA:a political history
|
|
Embryo and stem cell research in the USA is
inextricably linked with the abortion debate since 1973, when elective abortions became legal. Research has continued in an unregulated private sector.Here, the unique US cultural, political and
religious factors that have resulted in this situation are discussed. |
| April 14,2002 |
Order and Disorder in
the Nucleus
|
|
Fluorescence in situ hybridization combined with
three-dimensional microscopy has shown that chromosomes are not randomly strewn throughout the nucleus but are in fact fairly well organized, with different loci reproducibly found in different regions of the nucleus. |
| April 13,2002 |
Gene expression profiling diagnosis through DNA molecular computation
|
|
An Adleman DNA self-assembly computer that would use cDNA as input might be ideal for clinical cell discrimination and a neural network architecture would be appropriate for making the necessary classifications. |
| April 12,2002 |
The emerging power of chemical genetics |
|
Chemical genetic methods allow signal transduction pathways
to be probed in a domain-specific manner. This subtle
perturbation of function, when combined with classical genetic
and biochemical data, allows for a better understanding of
protein function. |
| April 11,2002 |
How signaling proteins
integrate multiple inputs: a comparison of N-WASP and Cdk2
|
|
Signal transduction proteins that can integrate multiple
upstream signals play a critical role in the complex regulatory
circuits that control cellular behavior. The two signaling node
proteins cyclin-dependent kinase 2 and the actin regulator
neuronal Wiskott–Aldrich syndrome protein have qualitatively
similar signaling properties. |
| April 10,2002 |
Proteomics of the nucleolus:more proteins,more functions?
|
|
The first encyclopedia of nucleolar proteins in a human cell is now available.Many of the 271 nucleolar proteins identified are involved in rRNA synthesis and processing, and in ribosome assembly,
but others are indicative of more diverse nucleolar functions. |
| April 09,2002 |
The angiotensin-converting enzyme gene family: genomics and pharmacology
|
|
Recently,genomic approaches have identified the first human
homologue of ACE, termed ACEH (or ACE2).ACEH differs in specificity and
physiological roles from ACE, which opens a potential new area for discovery
biology. |
| April 08,2002 |
Circular proteins – no end in sight
|
|
This article describes the discovery, structure, function and biosynthesis of the currently known circular proteins. |
| April 07,2002 |
Protein microarray
technology
|
|
Here,we discuss theoretical advantages and limitations of any miniaturized capture-molecule–ligand assay system and discusses how the use of protein microarrays will change diagnostic methods and genome and
proteome research. |
| April 06,2002 |
Heat-shock proteins as activators of the innate immune system
|
|
We discuss the similarities between the
responses to HSPs and LPS and also, emphasize that care must be taken when
working with preparations of HSPs in experimental settings and interpreting
experimental data. |
| April 05,2002 |
Medicinal chemistry and therapeutic
potential of CpG DNA
|
|
The observation that oligodeoxynucleotides containing CpG dinucleotides
(CpG DNA) exhibit several immunological effects has led to their use as
therapeutic agents and adjuvants for various diseases.This
article reviews recent progress in understanding the effects of CpG DNA, the
medicinal chemistry of CpG DNA, and its possible therapeutic applications. |
| April 04,2002 |
Seven-transmembrane receptors:crystals clarify
|
|
The X-ray structure of the photoreceptor rhodopsin has provided the first
atomic-resolution structure of a seven-transmembrane (7-TM) G-proteincoupled
receptor. |
| April 03,2002 |
Skiing Toward Nonstop mRNA Decay
|
|
One well-studied assurance mechanism in gene expression
in eukaryotes is nonsense-mediated messenger RNA (mRNA) decay (NMD).
NMD prevents the synthesis of potentially deleterious
truncated proteins when translation terminates prematurely. |
| April 02,2002 |
Chemical Database Techniques in Drug Discovery
|
|
Database searches based
on possible requirements for biological activity can identify compounds that might be suitable for
further analysis or indicate novel ways to achieve the desired activity. What considerations are
involved in the construction and searching of chemical databases? |
| April 01,2002 |
Development of therapeutics:
opportunities within complementary and alternative medicine
|
|
This article contrasts the regulatory framework for
dietary supplements and drugs, outlines the challenges of evaluating dietary
supplements for safety and clinical effectiveness, and describes the evolving
drug model for botanicals. |